home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  siRNA in Drug Discovery & Development  
  December 30, 2002

Others

 
     
  Strategic Research Institute, Hilton Torrey Pines, La Jolla, CA
March 24th-25th, 2003


SECTIONS:

- siRNA in Target Validation & Therapeutics
- Related Antisense Technologies
- Protein Profiling & Nucleic Acid Delivery
- Intellectual Property
- Partnering Opportunities

 
 
Organized by: Strategic Research Institute
Invited Speakers:
RNAi: Revolutionized Functional Genomics; Therapeutics Next?
Martin C. Woodle, Ph.D.
President
INTRADIGM CORPORATION


Novel Antisense Mechanisms for Drug Discovery & Therapeutics
Frank Bennett, Ph.D.
Vice President of Antisense Research
ISIS PHARMACEUTICALS, INC.

 
Deadline for Abstracts: tba
 
Registration: www.srinstitute.com
E-mail: gpascual@srinstitute.com
 
  Posted by:   Jennifer Law  
Host: 12.3.58.15
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.